索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]王心雨,王钰淇,罗皓文,等.线粒体生物发生与心血管疾病[J].国际心血管病杂志,2024,04:204-207.
点击复制

线粒体生物发生与心血管疾病(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年04期
页码:
204-207
栏目:
综述
出版日期:
2024-07-31

文章信息/Info

Title:
-
作者:
王心雨; 王钰淇; 罗皓文; 孙路轩; 张佳辉; 常盼
作者单位：710038 西安医学院第二临床医学院麻醉系（王心雨，王钰淇，罗皓文，孙路轩，张佳辉）；710038 西安医学院第二附属医院心内科（常盼）
Author(s):
-
关键词:
线粒体; 线粒体生物发生; 心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.04.004
文献标识码:
-
摘要:
线粒体是调控细胞能量供应、信号转导和凋亡等生命活动的半自主细胞器，其结构受损或功能失调可以导致多种心血管疾病（CVD）。线粒体生物发生是产生新的功能性线粒体并恢复正常线粒体功能的过程，在维持线粒体的稳态中发挥重要作用。线粒体生物发生的调控在CVD的发生、进展中具有保护作用。该文介绍线粒体生物发生对CVD的影响。
Abstract:
-

参考文献/References

[1] Peoples JN, Saraf A, Ghazal N, et al. Mitochondrial dysfunction and oxidative stress in heart disease[J]. Exp Mol Med, 2019, 51(12):1-13.
[2] Wilcox NS, Amit U, Reibel JB, et al. Cardiovascular disease and cancer: shared risk factors and mechanisms[J/OL]. Nat Rev Cardiol, 2024[2024-04-20]. https://pubmed.ncbi.nlm.nih. gov/38600368/.
[3] Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study[J]. Lancet, 2020, 395(10226):795-808.
[4] Pi?eiro DJ, Codato E, Mwangi J, et al. Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals[J]. Nat Rev Cardiol, 2023, 20(9):577-578.
[5] Redfern J, Tu Q, Hyun K, et al. Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease[J]. Cochrane Database Syst Rev, 2024, 3(3):CD011851.
[6] Liu Y, Huang YJ, Xu C, et al. Mitochondrial dysfunction and therapeutic perspectives in cardiovascular diseases[J]. Int J Mol Sci, 2022, 23(24):16053.
[7] XiaD, Liu Y, Wu P, et al. Current advances of mitochondrial dysfunction and cardiovascular disease and promising therapeutic strategies[J]. Am J Pathol, 2023, 193(10):1485-1500.
[8] Tahrir FG, Langford D, Amini S, et al. Mitochondrial quality control in cardiac cells: mechanisms and role in cardiac cell injury and disease[J]. J Cell Physiol, 2019, 234(6):8122-8133.
[9] Zhao T, Zhang JJ, Lei H, et al. NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity[J]. EMBO J, 2023, 42(16):e113258.
[10] Dorn GW2nd, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart[J]. Genes Dev, 2015, 29(19):1981-1991.
[11] Vega RB, Horton JL, Kelly DP. Maintaining ancient organelles:mitochondrial biogenesis and maturation[J]. Circ Res, 2015, 116(11):1820-1834.
[12] Popov LD. Mitochondrial biogenesis: an update[J]. J Cell Mol Med, 2020, 24(9):4892-4899.
[13] Bouchez C, Devin A. Mitochondrial biogenesis and mitochondrial reactive oxygen species (ROS): a complex relationship regulated by the cAMP/PKA signaling pathway[J]. Cells, 2019, 8(4):287.
[14] Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1[J]. Cell, 1999, 98(1):115-124.
[15] Malik N, Ferreira BI, Hollstein PE, et al. Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1[J]. Science, 2023, 380(6642):eabj5559.
[16] Bj?rkegren JLM, Lusis AJ. Atherosclerosis: recent developments[J]. Cell, 2022, 185(10):1630-1645.
[17] Li AQ, Gao M, Liu BL, et al. Mitochondrial autophagy:molecular mechanisms and implications for cardiovascular disease[J]. Cell Death Dis, 2022, 13(5):444.
[18] Vyas HS, Jadeja RN, Vohra A, et al. CORM-A1 alleviates pro-atherogenic manifestations via miR-34a-5p downregulation and an improved mitochondrial function[J]. Antioxidants (Basel), 2023, 12(5):997.
[19] Sazonova MA, Sinyov VV, Ryzhkova AI, et al. Role of mitochondrial genome mutations in pathogenesis of carotid atherosclerosis[J]. Oxid Med Cell Longev, 2017, 2017:6934394.
[20] Li P, Xie CL, Zhong JK, et al. Melatonin attenuates ox-LDL-induced endothelial dysfunction by reducing ER stress and inhibiting JNK/Mff signaling[J]. Oxid Med Cell Longev, 2021, 2021:5589612.
[21] Ala M, Eftekhar SP. Target sestrin2 to rescue the damaged organ:mechanistic insight into its function[J]. Oxid Med Cell Longev, 2021, 2021:8790369.
[22] Pedriali G, Ramaccini D, Bouhamida E, et al. Perspectives on mitochondrial relevance in cardiac ischemia/reperfusion injury[J]. Front Cell Dev Biol, 2022, 10:1082095.
[23] Kwong JQ, Davis J, Baines CP, et al. Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy[J]. Cell Death Differ, 2014, 21(8):1209-1217.
[24] Qi X, Wang J. Melatonin improves mitochondrial biogenesis through the AMPK/PGC1α pathway to attenuate ischemia/reperfusion-induced myocardial damage[J]. Aging(Albany NY), 2020, 12(8):7299-7312.
[25] Sun L, Zhao M, Yu XJ, et al. Cardioprotection by acetylcholine:a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway[J]. J Cell Physiol, 2013, 228(6):1238-1248.
[26] Vásquez-Trincado C, García-Carvajal I, Pennanen C, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease[J]. J Physiol, 2016, 594(3):509-525.
[27] Yue P, Zhang Y, Liu L, et al. Yap1modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload[J]. Theranostics, 2022, 12(16):7009-7031.
[28] Yu HJ, Zhang F, Yan PY, et al. LARP7 protects against heart failure by enhancing mitochondrial biogenesis[J]. Circulation, 2021, 143(20):2007-2022.
[29] Packer M. SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism[J]. Nat Rev Cardiol, 2023, 20(7):443-462.
[30] Sanches-Silva A, Testai L, Nabavi SF, et al. Therapeutic potential of polyphenols in cardiovascular diseases: regulation of mTOR signaling pathway[J]. Pharmacol Res, 2020, 152:104626.
[31] Horvath O, Ordog K, Bruszt K, et al. BGP-15 protects against heart failure by enhanced mitochondrial biogenesis and decreased fibrotic remodelling in spontaneously hypertensive rats[J]. Oxid Med Cell Longev, 2021, 2021:1250858.
[32] Chao YM, Wu KLH, Tsai PC, et al. Anomalous AMPK-regulated angiotensin AT1R expression and SIRT1-mediated mitochondrial biogenesis at RVLM in hypertension programming of offspring to maternal high fructose exposure[J]. J Biomed Sci, 2020, 27(1):68.
[33] Oller J, Gabandé-Rodríguez E, Ruiz-Rodríguez MJ, et al. Extracellular tuning of mitochondrial respiration leads to aortic aneurysm[J]. Circulation, 2021, 143(21):2091-2109.
[34] Xu S, Tao H, Cao W, et al. Ketogenic diets inhibit mitochondrial biogenesis and induce cardiac fibrosis[J]. Signal Transduct Target Ther, 2021, 6(1):54.
[35] Fan SW, Hu YH, You YP, et al. Role of resveratrol in inhibiting pathological cardiac remodeling[J]. Front Pharmacol, 2022, 13:924473.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（82300407）；陕西省科技厅自然基础重点项目（2023-JC-ZD-55）；陕西省教育厅2023年度服务地方专项科学研究计划（23JC059）；西安医学院大学生创新创业训练计划项目（S202311840059）
通信作者：常盼， E-mail：herepanpan@163.com
更新日期/Last Update: 2024-07-31